Home

Atlas Venture Fund XI, 10% Owner: Dyne Therapeutics DYN Sell · Filed 24/02/23

Trade details

Type
Insider sale
Amount
$3,621,603.4
Shares · price
159,542 sh · $22.70 a share
Held after
6,352,562 sh
Trade date
24/02/23
Filed
24/02/23
Days to filing
0 days

Sold 2.4% of holdings

Share of holding sold
2.4%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/24~24/03/24

Atlas Venture Fund XI's recent trades

  • Atlas Venture Fund XI

    Planned sale10b5-1 planKorro Bio

    $440.4K

    Filed 09/14

  • Atlas Venture Fund XI

    Planned sale10b5-1 planKorro Bio

    $110.4K

    Filed 09/11

  • Atlas Venture Fund XI

    Planned sale10b5-1 planKorro Bio

    $3,419

    Filed 08/26

  • Atlas Venture Fund XI

    Planned sale10b5-1 planKorro Bio

    $311.8K

    Filed 08/19

  • Atlas Venture Fund XI

    Planned sale10b5-1 planDyne Therapeutics

    $35.3M

    Filed 08/14